Short answer
HAEMONETICS CORP (HAE) filed an 8-K current report with the SEC on August 18, 2026 reporting Item 7.01 (Regulation FD Disclosure). Supply agreement with CSL Plasma for NexSys PCS devices, Persona PLUS technology and related U.S. disposables.
HAEMONETICS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Supply agreement with CSL Plasma for NexSys PCS devices, Persona PLUS technology and related U.S. disposables
- Non-exclusive arrangement with no minimum purchase commitments, limiting near-term revenue certainty
- CSL expects to transition an undetermined portion of U.S. plasma centers, with scope and timing unresolved
- Fiscal 2027 guidance unchanged pending clearer adoption and purchasing expectations
- Financial impact update planned with fiscal second-quarter earnings call in November 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HAEMONETICS CORP 8-K filings
Get the next HAE 8-K as it lands
Follow HAE for push alerts, or ask the research agent what this filing means.